AXNA vs RER1: Side-by-Side Comparison
Compare Amplifon S.p.A (AXNA) and Recordati Industria Chimica e Farmaceutica S.p.A (RER1) side by side: market cap EUR 2.62B vs EUR 10.43B, P/E 31.8 vs 22.8. Financials, growth and model signals on Bullrun.
| Metric | AXNA | RER1 |
|---|---|---|
| Company | Amplifon S.p.A | Recordati Industria Chimica e Farmaceutica S.p.A |
| Country / Exchange | Italy · F | Italy · F |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Drug Manufacturers - General |
| Market cap | EUR 2.62B | EUR 10.43B |
| P/E ratio | 31.8 | 22.8 |
| Dividend yield | 2.94% | 2.77% |
| Valuation model | 28.1% overvalued | 15.2% undervalued |
| Revenue (latest FY) | EUR 2.40B | EUR 1.58B |
| Revenue growth YoY | -0.6% | +9.1% |
| Net income | EUR 91.55M | EUR 385.97M |
| Gross margin | — | 72.9% |
| Diluted EPS | 0.40 | 1.85 |